MDT — MEDTRONIC PLC
Health Care · Medical Devices
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying MDT?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 2 tracked investors who changed their MDT position last quarter, 1 bought and 1 sold (50% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 53/100 in a Overheat regime). 1 congressional purchase, 1 sale disclosed in the last 6 months.
- +1 tracked investor added or increased positions last quarter (Ray Dalio)
- +5 tracked investors reported holding MDT at their latest filing
- −1 tracked investor reduced or exited last quarter (0 reduced, 1 sold out)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.
About MEDTRONIC PLC (MDT)
MEDTRONIC PLC (MDT) appears in the most recent 13F filings of 5 tracked institutional investors. MEDTRONIC PLC is classified in the Health Care sector (Medical Devices industry). The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $1.1B. Across recent filings, tracked investors recorded 4 new positions, 8 increased, 7 reduced, and 3 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in MDT
How many top investors track MDT
A small number of top investors own this.
MDT Ownership Composition
How MEDTRONIC PLC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant93.2%
- Macro6.8%
Tracked investors currently reporting MDT
- Ken GriffinJun 30, 2026Citadel AdvisorsShares7.8MValue$608.9M% Portfolio0.07%
- Izzy EnglanderJun 30, 2026Millennium ManagementShares1.5MValue$114M% Portfolio0.04%
- Ray DalioJun 30, 2026Bridgewater AssociatesShares482.5KValue$37.7M% Portfolio0.15%
- Steve CohenJun 30, 2026Point72 Asset ManagementShares148.4KValue$11.6M% Portfolio0.01%
- Paul Tudor JonesJun 30, 2026Tudor Investment CorpShares205.9KValue$16.1M% Portfolio0.02%
Recent activity
- $99.5MMay 15, 2026
- Sold$0(-100.00%)Aug 14, 2026
- New$59.3MMay 14, 2024
- Increased$108.5M(102.72%)Aug 14, 2024
- Reduced$52.5M(-57.74%)Nov 13, 2024
- Reduced$40.8M(-12.25%)Feb 13, 2025
- Reduced$15.2M(-66.83%)May 14, 2025
- Increased$17.6M(19.20%)Aug 13, 2025
- Increased$32.2M(67.29%)Nov 13, 2025
- Reduced$27.1M(-16.50%)Feb 13, 2026
- Reduced$22.1M(-9.61%)May 15, 2026
- Increased$37.7M(89.05%)Aug 14, 2026
- Increased$101.7M(587.46%)Nov 14, 2024
- Increased$91.2M(1.04%)Feb 14, 2025
- Reduced$22.6M(-77.99%)Jul 21, 2025
- Increased$29.2M(33.37%)Aug 14, 2025
- Reduced$22.2M(-30.35%)Nov 14, 2025
- Sold$0(-100.00%)Feb 17, 2026
- Increased$25.1M(280.13%)Aug 14, 2024
- Sold$0(-100.00%)Nov 14, 2024
- New$12.9MSep 16, 2024
- $7.3MMay 15, 2024
Frequently asked questions
- How many institutional investors hold MDT?
- 5 tracked institutional investors disclosed a position in MDT (MEDTRONIC PLC) in their most recent 13F filing.
- Who is the largest institutional holder of MDT?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in MDT, valued at $1.1B.
- Did institutional ownership of MDT increase or decrease?
- Across recent 13F filings, tracked investors recorded 4 new positions, 8 increased, 7 reduced, and 3 fully exited MDT.
- What sector is MDT in?
- MEDTRONIC PLC is classified in the Health Care GICS sector, Medical Devices industry.
- Where does this MDT ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.